(Q38046098)

27 August 2017

title

Protumor and antitumor functions of neutrophil granulocytes (English)

1 reference

Claudia Alexandra Dumitru

27 August 2017

author

series ordinal

2

object named as

Claudia A Dumitru

1 reference

27 August 2017

Sven Brandau

1

1 reference

27 August 2017

Stephan Lang

series ordinal

3

1 reference

27 August 2017

publication date

25 September 2012

1 reference

Seminars in Immunopathology

27 August 2017

published in

1 reference

27 August 2017

volume

35

1 reference

27 August 2017

issue

2

1 reference

27 August 2017

page(s)

163-176

1 reference

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Neutrophil granules and secretory vesicles in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Neutrophils and immunity: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Neutrophil granules: a library of innate immunity proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Peripheral blood neutrophil granulocytes from patients with head and neck squamous cell carcinoma functionally differ from their counterparts in healthy donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Origins of tumor-associated macrophages and neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

The terminology issue for myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Myeloid-derived suppressor cells in cancer patients: a clinical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Myeloid-Derived Suppressor Cells in Human Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Subsets, expansion and activation of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

G-CSF: a key regulator of neutrophil production, but that's not all!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Granulocyte-colony stimulating factor-producing pancreatic adenosquamous carcinoma showing aggressive clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Squamous cell carcinoma of the uterine cervix producing granulocyte colony-stimulating factor: a report of 4 cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Chemokines and chemokine receptors: new insights into cancer-related inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

The interleukin-8 pathway in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Sphingosine 1-phosphate enhances Fc gamma receptor-mediated neutrophil activation and recruitment under flow conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

High-mobility group box 1 and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Neutrophil granulocytes promote the migratory activity of MDA-MB-468 human breast carcinoma cells via ICAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Neutrophils enhance invasion activity of human cholangiocellular carcinoma and hepatocellular carcinoma cells: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

The metastatic niche: adapting the foreign soil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Neutrophils in the activation and regulation of innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Polymorphonuclear neutrophils and cancer: intense and sustained neutrophilia as a treatment against solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Neutrophils in antibody-based immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Chimaeric Lym-1 monoclonal antibody-mediated cytolysis by neutrophils from G-CSF-treated patients: stimulation by GM-CSF and role of Fc gamma -receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Interferon gamma induces in human neutrophils and macrophages expression of the mRNA for the high affinity receptor for monomeric IgG (Fc gamma R-I or CD64).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Double-Blind, Placebo-Controlled, Randomized Trial of Granulocyte-Colony Stimulating Factor During Postoperative Radiotherapy for Squamous Head and Neck Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

The transcriptional program of terminal granulocytic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Antibody-Dependent Killing of Tumor Cells by Polymorphonuclear Leukocytes. Involvement of Oxidative and Nonoxidative Mechanisms23

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Granzymes A and B are not expressed in human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Human neutrophils lack granzyme A, granzyme B, and perforin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Granzyme B and perforin: constitutive expression in human polymorphonuclear neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Targeting FcαRI on polymorphonuclear cells induces tumor cell killing through autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Enhanced FcαRI-mediated neutrophil migration towards tumour colonies in the presence of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Trial Watch: Experimental Toll-like receptor agonists for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Differential activation of RAGE by HMGB1 modulates neutrophil-associated NADPH oxidase activity and bacterial killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

NOD-like receptors and the innate immune system: coping with danger, damage and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Lactobacilli secreting a tumor antigen and IL15 activates neutrophils and dendritic cells and generates cytotoxic T lymphocytes against cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Neutrophil granulocytes are required for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

CD95L mediates tumor counterattack in vitro but induces neutrophil-independent tumor rejection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

The effects of FasL on inflammation and tumor survival are dependent on its expression levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Tumor-associated neutrophils: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Tumor entrained neutrophils inhibit seeding in the premetastatic lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Generation of Biologically Active Angiostatin Kringle 1-3 by Activated Human Neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0344-6

Antitumor effect of locally produced CD95 ligand

21 January 2018

1 reference

12 December 2020

Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma

1 reference

12 December 2020

Cytotoxic Effects of Peritoneal Neutrophils on a Syngeneic Rat Tumour

1 reference

12 December 2020

Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions

1 reference

12 December 2020

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

12 December 2020

Neutrophil-derived proteins: selling cytokines by the pound

1 reference

12 December 2020

Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy

1 reference

12 December 2020

The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer.

1 reference

12 December 2020

Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.

1 reference

12 December 2020

Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer

1 reference

12 December 2020

Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma

1 reference

12 December 2020

Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma

1 reference

12 December 2020

Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth

1 reference

12 December 2020

Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies

1 reference

12 December 2020

The production of colony-stimulating factors by thyroid carcinoma is associated with marked neutrophilia and eosinophilia

1 reference

12 December 2020

Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation

1 reference

12 December 2020

Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1

1 reference

12 December 2020

G-CSF: function and modes of action (Review).

1 reference

12 December 2020

Granulocyte colony-stimulating factor induction of normal human bone marrow progenitors results in neutrophil-specific gene expression

1 reference

12 December 2020

Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors

1 reference

12 December 2020

Clinically effective monoclonal antibody 3F8 mediates nonoxidative lysis of human neuroectodermal tumor cells by polymorphonuclear leukocytes

1 reference

12 December 2020

Neutrophil elastase induces cell proliferation and migration by the release of TGF-alpha, PDGF and VEGF in esophageal cell lines

1 reference

12 December 2020

Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells

1 reference

12 December 2020

10.1007/S00281-012-0344-6

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1019425815

0 references

1 reference